Phase I Clinical Investigation of 1,4-Dihydroxy-5,8-bis{{ {2-[(2-hydroxyethyl)amino]ethyl} amino}} -9,10-anthracenedione Dihydrochloride (NSC 301739), a New Anthracenedione

Daniel D. Von Hoff, Ester Pollard, John Kuhn, Edward Murray, Charles A. Coltman

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Clinical Investigation of 1,4-Dihydroxy-5,8-bis{{ {2-[(2-hydroxyethyl)amino]ethyl} amino}} -9,10-anthracenedione Dihydrochloride (NSC 301739), a New Anthracenedione'. Together they form a unique fingerprint.

Medicine and Dentistry

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology